Sarasin & Partners’s Pediatrix Medical MD Stock Holding History

Sarasin & Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,600	Closed	-$1.14M	–	137
2016 Q1	$1.14M	Buy	17,600 +3,200	+22%	+$212K	0.02%	110
2015 Q4	$1.03M	Buy	14,400 +2,600	+22%	+$192K	0.02%	113
2015 Q3	$906K	Sell	11,800 -11,800	-50%	-$952K	0.02%	115
2015 Q2	$1.75M	Sell	23,600 -6,400	-21%	-$461K	0.03%	110
2015 Q1	$2.17M	Sell	30,000 -41,000	-58%	-$2.85M	0.03%	108
2014 Q4	$4.69M	Hold	71,000	–	–	0.07%	90
2014 Q3	$3.89M	Hold	71,000	–	–	0.05%	97
2014 Q2	$4.13M	Sell	71,000 -37,800	-35%	-$2.22M	0.06%	96
2014 Q1	$6.74M	Buy	108,800 +6,200	+6%	+$361K	0.1%	77
2013 Q4	$5.48M	Hold	102,600	–	–	0.08%	86
2013 Q3	$5.15M	Buy	102,600 +17,400	+20%	+$849K	0.08%	79
2013 Q2	$3.9M	Buy	+85,200	New	+$3.81M	0.06%	103

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Sarasin & Partners's MD Position: Q2 2016 in Review

Sarasin & Partners sold out of Pediatrix Medical (MD) in Q2 2016, closing a stake of 17,600 shares — an estimated $1.14M sold.

Sarasin & Partners first reported a position in MD in Q2 2013 and held it in 12 quarters. The position peaked at $6.74M in Q1 2014. 391 funds tracked by Wall St. Rank hold MD as of Q2 2016.

Sarasin & Partners reported no remaining Pediatrix Medical position as of Q2 2016 after selling out during the quarter.
Sarasin & Partners sold 17,600 Pediatrix Medical shares in Q2 2016, an estimated $1.14M.
Sarasin & Partners first reported a position in Pediatrix Medical in Q2 2013 and held it in 12 quarters.
Sarasin & Partners's Pediatrix Medical position peaked at $6.74M in Q1 2014.
391 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2016.

Based on Sarasin & Partners's 13F filing for Q2 2016, filed 14 Jul 2016.